A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
Active, not recruiting · NCT06651229 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-28 | NCT06651229 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHRU de Strasbourg - Hopital de Hautepierre | Strasbourg | France | 3 |
| Clinica Univ. de Navarra | Pamplona | Spain | 42 |
| Concord Hospital | Concord | Australia | 6 |
| Hosp Univ Fund Jimenez Diaz | Madrid | Spain | 33 |
| Hospital Universitario Virgen Rocio | Seville | Spain | 2 |
| Institut Claudius Regaud | Toulouse | France | 7 |
| Institut Paoli-Calmettes | Marseille | France | 19 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 32 |
| Sir Charles Gairdner Hospital | Nedlands | Australia | 14 |